169 related articles for article (PubMed ID: 34627300)
21. STACKing the odds for adolescent survival: health service factors associated with full retention in care and adherence amongst adolescents living with HIV in South Africa.
Cluver L; Pantelic M; Toska E; Orkin M; Casale M; Bungane N; Sherr L
J Int AIDS Soc; 2018 Sep; 21(9):e25176. PubMed ID: 30240121
[TBL] [Abstract][Full Text] [Related]
22. Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self-report in predicting viral suppression in a cluster-randomized trial.
Kizito S; Namuwonge F; Brathwaite R; Neilands TB; Nabunya P; Bahar OS; Damulira C; Mwebembezi A; Mellins C; McKay MM; Ssewamala FM
J Int AIDS Soc; 2022 Sep; 25(9):e25990. PubMed ID: 36052462
[TBL] [Abstract][Full Text] [Related]
23. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda.
Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R
AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196
[TBL] [Abstract][Full Text] [Related]
24. Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
Djiyou ABD; Penda CI; Madec Y; Ngondi GD; Moukoko A; Varloteaux M; de Monteynard LA; Moins C; Moukoko CEE; Aghokeng AF
BMC Pediatr; 2023 Mar; 23(1):119. PubMed ID: 36922769
[TBL] [Abstract][Full Text] [Related]
25. Closing the HIV Treatment Gap for Adolescents in Windhoek, Namibia: A Retrospective Analysis of Predictors of Viral Non-Suppression.
Munyayi FK; van Wyk B
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429431
[TBL] [Abstract][Full Text] [Related]
26. Clinic-level and individual-level factors that influence HIV viral suppression in adolescents and young adults: a national survey in Kenya.
Njuguna I; Neary J; Mburu C; Black D; Beima-Sofie K; Wagner AD; Mugo C; Evans Y; Guthrie B; Itindi J; Onyango A; Oyiengo L; Richardson BA; Wamalwa D; John-Stewart G
AIDS; 2020 Jun; 34(7):1065-1074. PubMed ID: 32287060
[TBL] [Abstract][Full Text] [Related]
27. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
28. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
[TBL] [Abstract][Full Text] [Related]
29. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
[TBL] [Abstract][Full Text] [Related]
30. Short Communication: Early Antiretroviral Therapy Is Associated with Better Viral Suppression and Less HIV Drug Resistance After Implementation of Universal Treatment in South Africa.
Dorward J; Drain PK; Osman F; Sookrajh Y; Pillay M; Moodley P; Garrett N
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):297-299. PubMed ID: 31663368
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
32. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
33. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.
Mutumba M; Musiime V; Lepkwoski JM; Harper GW; Snow RC; Resnicow K; Bauermeister JA
AIDS Care; 2016 Jul; 28(7):807-15. PubMed ID: 27294696
[TBL] [Abstract][Full Text] [Related]
34. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
[TBL] [Abstract][Full Text] [Related]
35. Barriers to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review protocol.
Hlophe LD; Tamuzi JL; Shumba C; Nyasulu PS
PLoS One; 2022; 17(9):e0273435. PubMed ID: 36178934
[TBL] [Abstract][Full Text] [Related]
36. Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey.
Woldesenbet SA; Kufa-Chakezha T; Lombard C; Manda S; Cheyip M; Ayalew K; Puren A
HIV Med; 2021 Oct; 22(9):805-815. PubMed ID: 34213065
[TBL] [Abstract][Full Text] [Related]
37. Psychosocial Support Programme Improves Adherence and Health Systems Experiences for Adolescents on Antiretroviral Therapy in Mpumalanga Province, South Africa.
Okonji EF; Wyk BV; Hughes GD; Mukumbang FC
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497544
[TBL] [Abstract][Full Text] [Related]
38. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
39. Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa.
Shoko C; Chikobvu D
Theor Biol Med Model; 2018 Jul; 15(1):10. PubMed ID: 30008270
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.
Evans D; Menezes C; Mahomed K; Macdonald P; Untiedt S; Levin L; Jaffray I; Bhana N; Firnhaber C; Maskew M
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):892-900. PubMed ID: 23373540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
